Migranal and Suicidal ideation - a phase IV clinical study of FDA data

Summary:

Suicidal ideation is reported as a side effect among people who take Migranal (dihydroergotamine mesylate), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Relpax, and have Narcolepsy.

The phase IV clinical study analyzes which people have Suicidal ideation when taking Migranal. It is created by eHealthMe based on reports of 531 people who have side effects when taking Migranal from the FDA, and is updated regularly.

What is Migranal?

Migranal has active ingredients of dihydroergotamine mesylate. It is often used in migraine. eHealthMe is studying from 560 Migranal users. Check the latest studies of Migranal.

What is Suicidal ideation?

Suicidal ideation is found to be associated with 1,981 drugs and 2,341 conditions by eHealthMe. Check the latest studies of Suicidal ideation.

On Jul, 06, 2026

531 people reported to have side effects when taking Migranal.
Among them, 21 people (3.95%) have Suicidal ideation.

Among these 21 people:

How long have people been on Migranal when they have Suicidal ideation? *

What is the gender of people who have Suicidal ideation when taking Migranal? *

female: 100 %
male: 0.0 %

What is the age of people who have Suicidal ideation when taking Migranal? *

What are other drugs people take besides Migranal? *

What are other side effects people have besides Suicidal ideation? *

Memory Loss: 8 people, 38.10%
Headache (pain in head): 7 people, 33.33%
Stress And Anxiety: 7 people, 33.33%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 7 people, 33.33%
Depression: 5 people, 23.81%
Head Injury: 4 people, 19.05%
Pain: 4 people, 19.05%
Post Concussion Syndrome: 4 people, 19.05%
Drug Ineffective: 4 people, 19.05%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 19.05%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 57.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 42.86%
Stress And Anxiety: 4 people, 19.05%
Pain: 4 people, 19.05%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 14.29%
Depression: 3 people, 14.29%
Sleep Disorder: 1 person, 4.76%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 1 person, 4.76%
Insomnia (sleeplessness): 1 person, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Migranal and have Suicidal ideation?

- Check whether Suicidal ideation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Migranal:

Migranal (560 reports)

Suicidal ideation treatments and more:

Suicidal ideation (109,012 reports)

Browse all side effects of Migranal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Suicidal ideation:

Suicidal ideation (1,981 drugs)

Browse all the conditions that are associated with Suicidal ideation:

Suicidal ideation (2,341 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate (the active ingredients of Migranal) and Migranal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.